{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:05:02Z","timestamp":1769169902818,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bmcl.2021.128050","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T15:49:38Z","timestamp":1618933778000},"page":"128050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1896-3708","authenticated-orcid":false,"given":"Birgit","family":"Wilding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7966-4672","authenticated-orcid":false,"given":"A. Elisa","family":"Pasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4125-320X","authenticated-orcid":false,"given":"Nicola","family":"E. A. Chessum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier A.","family":"Pierrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamas","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Tomlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erald","family":"Shehu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Meirion","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2311-7407","authenticated-orcid":false,"given":"Bradleigh","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7475-9704","authenticated-orcid":false,"given":"Esther N.","family":"Arwert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Thapaliya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2157-8149","authenticated-orcid":false,"given":"Ramya","family":"Salimraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"van Montfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agi","family":"Skawinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9440-4094","authenticated-orcid":false,"given":"Keith","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2721-0089","authenticated-orcid":false,"given":"Gary","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1121-6985","authenticated-orcid":false,"given":"Matthew D.","family":"Cheeseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.128050_b0005","unstructured":"Uniprot: Human ERAP1 Q9NZO8, Human ERAP2 Q6P179."},{"key":"10.1016\/j.bmcl.2021.128050_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02463","article-title":"How ERAP1 and ERAP2 shape the peptidomes of disease-associated MHC-I proteins","volume":"9","author":"L\u00f3pez de Castro","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.bmcl.2021.128050_b0015","doi-asserted-by":"crossref","first-page":"26709","DOI":"10.1073\/pnas.1912070116","article-title":"Mechanism for antigenic peptide selection by endoplasmic reticulum aminopeptidase 1","volume":"116","author":"Giastas","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.bmcl.2021.128050_b0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coi.2015.12.007","article-title":"The urgent need to recover MHC class I in cancers for effective immunotherapy","volume":"39","author":"Garrido","year":"2016","journal-title":"Curr Opin Immunol."},{"key":"10.1016\/j.bmcl.2021.128050_b0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/14728222.2020.1751821","article-title":"ERAP1: a potential therapeutic target for a myriad of diseases","volume":"24","author":"Reeves","year":"2020","journal-title":"Expert Opin Ther Targets."},{"key":"10.1016\/j.bmcl.2021.128050_b0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.humimm.2019.02.013","article-title":"The role of ERAP1 in autoinflammation and autoimmunity","volume":"80","author":"Pepelyayeva","year":"2019","journal-title":"Hum Immunol."},{"key":"10.1016\/j.bmcl.2021.128050_b0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.humimm.2019.02.014","article-title":"Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer","volume":"80","author":"Compagnone","year":"2019","journal-title":"Hum Immunol."},{"key":"10.1016\/j.bmcl.2021.128050_b0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12885-020-06832-2","article-title":"Polymorphisms in endoplasmic reticulum aminopeptidase genes are associated with cervical cancer risk in a chinese Han population","volume":"20","author":"Li","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bmcl.2021.128050_b0045","unstructured":"Uniprot: Mouse ERAP1 Q9EQH2."},{"key":"10.1016\/j.bmcl.2021.128050_b0050","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.4049\/jimmunol.1500654","article-title":"ERAAP shapes the peptidome associated with classical and nonclassical MHC class I molecules","volume":"197","author":"Nagarajan","year":"2016","journal-title":"J Immunol."},{"key":"10.1016\/j.bmcl.2021.128050_b0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molimm.2012.10.006","article-title":"Immune surveillance for ERAAP dysfunction","volume":"55","author":"Nagarajan","year":"2013","journal-title":"Mol Immunol."},{"key":"10.1016\/j.bmcl.2021.128050_b0060","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2174\/0929867325666180214111849","article-title":"Inhibitors of ER aminopeptidase 1 and 2: from design to clinical application","volume":"26","author":"Dimitris","year":"2019","journal-title":"Curr Med Chem."},{"key":"10.1016\/j.bmcl.2021.128050_b0065","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1016\/j.bmcl.2013.07.024","article-title":"Novel selective inhibitors of aminopeptidases that generate antigenic peptides","volume":"23","author":"Papakyriakou","year":"2013","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmcl.2021.128050_b0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/acs.jmedchem.9b00293","article-title":"Discovery of selective inhibitors of endoplasmic reticulum aminopeptidase 1","volume":"63","author":"Maben","year":"2020","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128050_b0075","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1021\/acs.jmedchem.9b02123","article-title":"Targeting the regulatory site of ER aminopeptidase 1 leads to the discovery of a natural product modulator of antigen presentation","volume":"63","author":"Liddle","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2021.128050_b0080","doi-asserted-by":"crossref","first-page":"19890","DOI":"10.1073\/pnas.1309781110","article-title":"Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses","volume":"110","author":"Zervoudi","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.bmcl.2021.128050_b0085","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/acsmedchemlett.9b00002","article-title":"High-resolution crystal structure of endoplasmic reticulum aminopeptidase 1 with bound phosphinic transition-state analogue inhibitor","volume":"10","author":"Giastas","year":"2019","journal-title":"ACS Med Chem Lett."},{"key":"10.1016\/j.bmcl.2021.128050_b0090","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1021\/acs.jmedchem.6b01031","article-title":"Optimization and structure\u2013activity relationships of phosphinic pseudotripeptide inhibitors of aminopeptidases that generate antigenic peptides","volume":"59","author":"Kokkala","year":"2016","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128050_b0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.xphs.2018.10.006","article-title":"Physicochemical QSAR analysis of passive permeability across Caco-2 monolayers","volume":"108","author":"Lanevskij","year":"2019","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.bmcl.2021.128050_b0100","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/mp500437e","article-title":"Beyond Overton\u2019s rule: quantitative modeling of passive permeation through tight cell monolayers","volume":"11","author":"Filipe","year":"2014","journal-title":"Mol Pharm."},{"key":"10.1016\/j.bmcl.2021.128050_b0105","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00262-019-02358-0","article-title":"Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1)","volume":"68","author":"Koumantou","year":"2019","journal-title":"Cancer Immunol Immunother."},{"key":"10.1016\/j.bmcl.2021.128050_b0110","unstructured":"https:\/\/www.rcsb.org\/structure\/6M8P, accessed September 2020."},{"key":"10.1016\/j.bmcl.2021.128050_h0115","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1021\/jm9900164","article-title":"Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure\u2212activity study","volume":"42","author":"Vassiliou","year":"1999","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128050_h0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0022-328X(01)01388-2","article-title":"Enantioselective synthesis of phosphinyl peptidomimetics via an asymmetric Michael reaction of phosphinic acids with acrylate derivatives","volume":"646","author":"Liu","year":"2002","journal-title":"J Organomet Chem."},{"key":"10.1016\/j.bmcl.2021.128050_h0125","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1021\/jo400798f","article-title":"Enantioselective synthesis of H-phosphinic acids bearing natural amino acid residues","volume":"78","author":"Yao","year":"2013","journal-title":"J Org Chem."},{"key":"10.1016\/j.bmcl.2021.128050_h0130","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1021\/ja00064a011","article-title":"Total synthesis of (+)-A83543A [(+)-lepicidin A]","volume":"115","author":"Evans","year":"1993","journal-title":"J Am Chem Soc."},{"issue":"1972\u20131999","key":"10.1016\/j.bmcl.2021.128050_b0120","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1039\/p19840002845","article-title":"1-Aminoalkylphosphonous acids. Part 1. Isosteres of the protein amino acids","volume":"1","author":"Baylis","year":"1984","journal-title":"J Chem Soc, Perkin Trans."},{"key":"10.1016\/j.bmcl.2021.128050_h0140","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/S0957-4166(03)00537-8","article-title":"High-performance liquid chromatographic enantiomer separation and determination of absolute configurations of phosphinic acid analogues of dipeptides and their \u03b1-aminophosphinic acid precursors","volume":"14","author":"L\u00e4mmerhofer","year":"2003","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.bmcl.2021.128050_h0145","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.bmcl.2008.01.107","article-title":"Individual stereoisomers of phosphinic dipeptide inhibitorof leucine aminopeptidase","volume":"18","author":"Mucha","year":"2008","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmcl.2021.128050_b0130","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1021\/jm990483l","article-title":"Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: Synthesis, biological properties, and anticeptive activities","volume":"43","author":"Chen","year":"2000","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128050_b0135","unstructured":"HPLC purification using a TFA modifier resulted in partial decomposition of the final product and low yields in our hands; a formic acid modifier gave higher yields and a stable product."},{"key":"10.1016\/j.bmcl.2021.128050_b0140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1042\/BJ20102049","article-title":"Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides","volume":"435","author":"Zervoudi","year":"2011","journal-title":"Biochem J."},{"key":"10.1016\/j.bmcl.2021.128050_b0145","unstructured":"Moka, Version: 3.1.3, Modules, MDPict: 0.22.4, pKa predictions: 4.16.7 (QPFILE=19, COEFILE=20, DESFILE=19), Build date: May 24 2018."},{"key":"10.1016\/j.bmcl.2021.128050_b0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccell.2017.06.005","article-title":"Choose and use your chemical probe wisely to explore cancer biology","volume":"32","author":"Blagg","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmcl.2021.128050_b0155","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1021\/acsmedchemlett.8b00364","article-title":"Privileged structures and polypharmacology within and between protein families","volume":"9","author":"Meyers","year":"2018","journal-title":"ACS Med Chem Lett."},{"key":"10.1016\/j.bmcl.2021.128050_b0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.gene.2014.09.025","article-title":"Evolutionary analysis of the mammalian M1 aminopeptidases reveals conserved exon structure and gene death","volume":"552","author":"Maynard","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.bmcl.2021.128050_b0165","unstructured":"Uniprot: Human APN P15144."},{"key":"10.1016\/j.bmcl.2021.128050_h0190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1349-7006.2010.01826.x","article-title":"Aminopeptidase N (CD13) as a target for cancer chemotherapy","volume":"102","author":"Wickstrom","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bmcl.2021.128050_h0195","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1021\/acs.jmedchem.9b00757","article-title":"Novel human aminopeptidase N inhibitors: discovery and optimization of subsite binding interactions","volume":"62","author":"Lee","year":"2019","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128050_b0175","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41598-017-01542-5","article-title":"The rational design of therapeutic peptides for aminopeptidase N using a substrate-based approach","volume":"7","author":"Joshi","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.bmcl.2021.128050_b0180","unstructured":"PDB: https:\/\/www.rcsb.org\/structure\/4FYR, accessed September 2020."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21002766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21002766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:39:32Z","timestamp":1760773172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21002766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":41,"alternative-id":["S0960894X21002766"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128050","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128050"}}